Literature DB >> 12865402

Osteopontin: a bridge between bone and the immune system.

Ellen M Gravallese1.   

Abstract

The molecular mechanisms underlying the putative role of osteopontin in the chronic inflammatory disease rheumatoid arthritis are unclear. A study in a murine model of arthritis now demonstrates that a specific antibody directed against the exposed osteopontin epitope SLAYGLR is capable of preventing inflammatory cell infiltration in arthritic joints.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12865402      PMCID： PMC164297          DOI： 10.1172/JCI19190

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  13 in total

1.  Comment on "The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease".

Authors:  Thomas Blom; Ahnders Franzén; Dick Heinegård; Rikard Holmdahl
Journal:  Science       Date:  2003-03-21       Impact factor: 47.728

Review 2.  Osteopontin expression and function: role in bone remodeling.

Authors:  D T Denhardt; M Noda
Journal:  J Cell Biochem Suppl       Date:  1998

3.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

4.  Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts.

Authors:  P K Petrow; K M Hummel; J Schedel; J K Franz; C L Klein; U Müller-Ladner; J Kriegsmann; P L Chang; C W Prince; R E Gay; S Gay
Journal:  Arthritis Rheum       Date:  2000-07

5.  Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis.

Authors:  Shiro Ohshima; Hideyuki Kobayashi; Norihiko Yamaguchi; Katsuhiro Nishioka; Mitsuko Umeshita-Sasai; Toru Mima; Shintaro Nomura; Shigeyuki Kon; Manabu Inobe; Toshimitsu Uede; Yukihiko Saeki
Journal:  Arthritis Rheum       Date:  2002-04

6.  Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis.

Authors:  Nobuchika Yamamoto; Fumihiko Sakai; Shigeyuki Kon; Junko Morimoto; Chiemi Kimura; Harumi Yamazaki; Ikuko Okazaki; Nobuo Seki; Takashi Fujii; Toshimitsu Uede
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

7.  Macrophages express osteopontin during repair of myocardial necrosis.

Authors:  C E Murry; C M Giachelli; S M Schwartz; R Vracko
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

8.  Receptor-ligand interaction between CD44 and osteopontin (Eta-1).

Authors:  G F Weber; S Ashkar; M J Glimcher; H Cantor
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

9.  OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.

Authors:  Y Y Kong; H Yoshida; I Sarosi; H L Tan; E Timms; C Capparelli; S Morony; A J Oliveira-dos-Santos; G Van; A Itie; W Khoo; A Wakeham; C R Dunstan; D L Lacey; T W Mak; W J Boyle; J M Penninger
Journal:  Nature       Date:  1999-01-28       Impact factor: 49.962

10.  Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression.

Authors:  M A Chellaiah; N Kizer; R Biswas; U Alvarez; J Strauss-Schoenberger; L Rifas; S R Rittling; D T Denhardt; K A Hruska
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138
View more
  50 in total

1.  Comparison of gene expression between mandibular and iliac bone-derived cells.

Authors:  Jung-Tae Lee; So-Young Choi; Hyung-Lak Kim; Jae-Young Kim; Heon-Jin Lee; Tae-Geon Kwon
Journal:  Clin Oral Investig       Date:  2014-11-05       Impact factor: 3.573

Review 2.  Apolipoprotein D.

Authors:  Eric Rassart; Frederik Desmarais; Ouafa Najyb; Karl-F Bergeron; Catherine Mounier
Journal:  Gene       Date:  2020-06-15       Impact factor: 3.688

3.  Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking.

Authors:  Adriana Heguy; Timothy P O'Connor; Karsta Luettich; Stefan Worgall; Adam Cieciuch; Ben-Gary Harvey; Neil R Hackett; Ronald G Crystal
Journal:  J Mol Med (Berl)       Date:  2006-03-07       Impact factor: 4.599

4.  Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence.

Authors:  Daniel J Caruso; Adrienne J K Carmack; Vinata B Lokeshwar; Robert C Duncan; Mark S Soloway; Bal L Lokeshwar
Journal:  Clin Cancer Res       Date:  2008-07-01       Impact factor: 12.531

5.  Plasma level of Osteopontin does not respond to total replacement Surgery in patients with severe Primary knee/Hip Osteoarthritis.

Authors:  Ramy Abdelnaby; Sameh El Deeb; Ali Khachab; Klaus Bläsius; Markus Tingart; Björn Rath
Journal:  J Orthop       Date:  2017-06-23

6.  Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway.

Authors:  Xianmin Luo; Megan K Ruhland; Ermira Pazolli; Anne C Lind; Sheila A Stewart
Journal:  Mol Cancer Res       Date:  2011-06-14       Impact factor: 5.852

7.  The possible roles of OPN-regulated CEACAM1 expression in promoting the survival of activated T cells and the apoptosis of oral keratinocytes in oral lichen planus patients.

Authors:  Gui-Xiang Liu; Qi Xie; Cheng-Jun Zhou; Xiao-Ying Zhang; Bo-Long Ma; Cheng-Qin Wang; Feng-Cai Wei; Xun Qu; Shan-Zhen Sun
Journal:  J Clin Immunol       Date:  2011-06-14       Impact factor: 8.317

8.  Role of osteopontin in amplification and perpetuation of rheumatoid synovitis.

Authors:  Guangwu Xu; Hong Nie; Ningli Li; Wenxin Zheng; Dongqing Zhang; Guozhang Feng; Liqing Ni; Rong Xu; Jian Hong; Jingwu Z Zhang
Journal:  J Clin Invest       Date:  2005-03-03       Impact factor: 14.808

9.  The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways.

Authors:  Donald Courter; Hongbin Cao; Shirley Kwok; Christina Kong; Alice Banh; Peiwen Kuo; Donna M Bouley; Carmen Vice; Odd Terje Brustugun; Nicholas C Denko; Albert C Koong; Amato Giaccia; Quynh-Thu Le
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

10.  The Dietary Supplement Protandim Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx Mice.

Authors:  Muhammad Muddasir Qureshi; Warren C McClure; Nicole L Arevalo; Rick E Rabon; Benjamin Mohr; Swapan K Bose; Joe M McCord; Brian S Tseng
Journal:  J Diet Suppl       Date:  2010-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.